BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel


NEWSLETTERS
FREENewsletters
Archive

NEWS
News bySubject
News byDisease
News byDate
PLoS
SearchNews

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
BiotechBay™
BiotechBeach™
Genetown™
PharmCountry™
BioCapital™
BioMidwest™
BioNC™
BioForest™
SouthernPharm™
BioCanadaEast™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
CompanyProfiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event

RESOURCES
RealEstate
Business Opportunities
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Urologix, Inc. (NQ: ULGX)
0.5000 USD  +0.0100 (+2.04%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.5100
Bid (Size) 0.4800 (900)
Ask (Size) 0.5000 (8000)
Prev. Close 0.4900
Today's Range 0.4651 - 0.5199
52wk Range 0.3274 - 1.290
Shares Outstanding 20,908,932
Dividend Yield N/A
Top News
More News
Urologix, Inc. (ULGX) Tops Q3 Views
May 01, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8295295 for the full story. Read More
from StreetInsider.com News Articles
Urologix Reports Fiscal Year 2013 Third Quarter Results and Reaffirms Annual Guidance
May 01, 2013
from GlobeNewswire News Releases

More News
Read More
Urologix to Host Its Fiscal Year 2013 Third Quarter Conference Call
April 25, 2013
from Business Wire News Releases
Urologix Receives Extension From NASDAQ to Regain Compliance With Listing Requirements
April 17, 2013
from GlobeNewswire News Releases
Urologix Reports Important Milestone in Prostiva(R) RF Therapy Licensing Deal
April 08, 2013
category Benzinga , News , ULGX
from Latest Articles from Benzinga.com
Urologix Announces Important Milestone in Prostiva(R) RF Therapy Licensing Agreement
April 08, 2013
from GlobeNewswire News Releases
Urologix Reports Fiscal Year 2013 Second Quarter Results and Reaffirms Annual Guidance
February 05, 2013
from GlobeNewswire News Releases
Urologix to Host Its Fiscal Year 2013 Second Quarter Conference Call
January 30, 2013
from Business Wire News Releases
Urologix Names Greg Fluet as New CEO
January 30, 2013
from GlobeNewswire News Releases
Urologix Receives NASDAQ Notification Related to Minimum Bid Price Requirement
January 29, 2013
from GlobeNewswire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
About BioSpace | Contact Us | Privacy Statement | Terms of Use
Post Your News | Post Event | Post Jobs | Post Company Profile | Advertising Opportunities

RSS FEED All News | Breaking News | Featured Stories

© 2007 BioSpace, Inc - an onTargetjobs company
Visit other onTargetjobs companies
Niche Job Boards | Biotechnology Jobs | Healthcare Jobs | Nursing Jobs | Accounting Jobs | Hospitality Jobs
Hospitality Jobs Canada | Hospitality Jobs UK